3M to invest nearly $150 million on expanding biopharma filtration capabilities
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe.
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe.
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
The Awards recognizes standout digital health & medical technology products and companies
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products
The partnership will capitalize on the combined capabilities of the two organizations
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Apollo continues to invest in genomics technology and research for better patient care
Subscribe To Our Newsletter & Stay Updated